| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
Institute of Pharmacology (C.M., G.T., P.P., P.N.), Catholic University Medical School, Largo Francesco Vito 1, 00168 Rome, Italy; and Department of Endocrinology (A.G.), St. Bartholomews Hospital, London EC1A 7BE, United Kingdom
Address all correspondence and requests for reprints to: Prof. Pierluigi Navarra, Institute of Pharmacology, Catholic University Medical School, Largo Francesco Vito 1, 00168 Rome, Italy.
Both the cytokine, interleukin-1 (IL-1), and the gaseous neurotransmitters, nitric oxide (NO) and carbon monoxide (CO), have been implicated in the control of neuroendocrine functions, such as the release of CRH and luteotropic hormone-releasing hormone from the hypothalamus. Though increased levels of IL-1 in this brain region are unambiguously associated with enhanced CRH and reduced luteotropic hormone-releasing hormone release, the net effects of the two gases are still unclear, but in vivo and in vitro evidence suggests that the generation of NO and CO within the hypothalamus might counteract the stimulatory effects of IL-1 and bacterial lipopolysaccharide on the neuroendocrine stress axis.
In this study, we have investigated the effects of NO and CO on the release of immunoreactive (ir)-IL-1ß from the rat hypothalamus in vitro. It was observed that the NO donor, sodium nitroprusside (SNP), stimulates ir-IL-1ß release under basal conditions, whereas the increase in CO levels obtained with hemin, the CO precursor through the heme oxygenase pathway, has no effect on basal ir-IL-1ß release but inhibits release stimulated by high K+ concentrations. The opposite effects of the two gases on cytokine release seemed to be caused by the activation of different signaling pathways, because: 1) SNP, but not CO-saturated solutions, is able to increase cyclic GMP levels in hypothalamic tissue; 2) CO-saturated solutions increase PGE2 production and release from the hypothalamic explants, whereas SNP has no effect; 3) SNP-stimulated ir-IL-1ß release is counteracted by a selective inhibitor of soluble guanylyl cyclase, LY 83583, but not by a cyclooxygenase inhibitor, indomethacin; and 4) conversely, indomethacin, but not LY 83583, reverses the inhibitory effect of hemin on K+-stimulated ir-IL-1ß release.
It is concluded that NO and CO signal in the rat hypothalamus via the activation of soluble guanylyl cyclase and cyclooxygenase, respectively.
This article has been cited by other articles:
![]() |
A. A. Steiner and L. G. S. Branco Carbon monoxide is the heme oxygenase product with a pyretic action: evidence for a cGMP signaling pathway Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2001; 280(2): R448 - R457. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Navarra, F. Miceli, G. Tringali, F. Minici, M. G. Pardo, A. Lanzone, S. Mancuso, and R. Apa Evidence for a Functional Link between the Heme Oxygenase-Carbon Monoxide Pathway and Corticotropin-Releasing Hormone Release from Primary Cultures of Human Trophoblast Cells J. Clin. Endocrinol. Metab., January 1, 2001; 86(1): 317 - 323. [Abstract] [Full Text] |
||||
![]() |
G. Pistritto, G. Ciabattoni, C. Mancuso, G. Tringali, P. Preziosi, and P. Navarra Signaling pathways involved in lipopolysaccharide stimulation of prostaglandin production by rat hypothalamic astroglial cells Innate Immunity, August 1, 2000; 6(4): 307 - 311. [Abstract] [PDF] |
||||
![]() |
A. A. Steiner and L. G. S. Branco Central CO-heme oxygenase pathway raises body temperature by a prostaglandin-independent way J Appl Physiol, May 1, 2000; 88(5): 1607 - 1613. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Steiner, E. Colombari, and L. G. S. Branco Carbon monoxide as a novel mediator of the febrile response in the central nervous system Am J Physiol Regulatory Integrative Comp Physiol, August 1, 1999; 277(2): R499 - R507. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Jasmin, G. Janni, H. J. Manz, and S. D. Rabkin Activation of CNS Circuits Producing a Neurogenic Cystitis: Evidence for Centrally Induced Peripheral Inflammation J. Neurosci., December 1, 1998; 18(23): 10016 - 10029. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |